TScan Therapeutics Inc.

1.72
0.09 (5.52%)
At close: Apr 24, 2025, 3:59 PM
1.70
-1.02%
After-hours: Apr 24, 2025, 04:13 PM EDT

TScan Therapeutics Revenue

TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending December 31, 2024, TScan Therapeutics generated $665K in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.52K
Employees
194
Market Cap
97.34M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 2.82M -86.62%
Dec 31, 2023 21.05M +55.52%
Dec 31, 2022 13.54M +33.47%
Dec 31, 2021 10.14M +834.65%
Dec 31, 2020 1.08M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.